FindTrial
Sign In

Utility of protein levels in blood to identify complications after pancreatic surgeries in a cancer institute

Utility of serum albumin levels to predict postoperative complications in pancreatic surgeries in a tertiary cancer institute

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029642
Enrollment
169
Registered
2020-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C25- Malignant neoplasm of pancreas

Interventions

Intervention1: none: none Control Intervention1: none: none

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients above 18 years undergoing elective major pancreatic resections under General Anaesthesia

Exclusion criteria

Exclusion criteria: Other abdominal surgeries (liver resections, gall bladder, gastrectomies, oesophagectomies and colorectal surgeries)

Design outcomes

Primary

MeasureTime frame
Primary outcomes measured will be short term postoperative complications as per Clavien Dindo classificationTimepoint: Follow up for one month after surgery—

Secondary

MeasureTime frame
Need for vasopressors, need for postoperative ventilation, ICU and Hospital Length of Stay (LOS), status at hospital discharge or at 30 days, whichever is earlier (alive or dead)Timepoint: Follow up for one month after surgery—

Countries

India

Contacts

Public ContactNiki Patel

Tata Memorial Hospital,Parel Mumbai

jmalini2007@rediffmail.com024177000-7045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026